(Q42811762)

7 November 2017

title

The CB1 endocannabinoid system modulates adipocyte insulin sensitivity (English)

1 reference

7 November 2017

main subject

endocannabinoid system

0 references

1 reference

1 reference

Roja Motaghedi

1

1 reference

7 November 2017

Timothy E McGraw

series ordinal

2

1 reference

7 November 2017

publication date

12 June 2008

1 reference

7 November 2017

1 reference

7 November 2017

volume

16

1 reference

7 November 2017

issue

8

1 reference

7 November 2017

page(s)

1727-1734

1 reference

Predictability of childhood adiposity and insulin for developing insulin resistance syndrome (syndrome X) in young adulthood: the Bogalusa Heart Study

7 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.309

Endocrinology of adipose tissue - an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.309

Targeting fat to prevent diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.309

Endocannabinoids and the control of energy balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.309

Understanding metabolic homeostasis and imbalance: what is the role of the endocannabinoid system?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.309

Endocannabinoid control of food intake and energy balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.309

Activation of the peripheral endocannabinoid system in human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.309

The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.309

Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.309

The emerging role of the endocannabinoid system in endocrine regulation and energy balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.309

The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.309

GLUT4 is retained by an intracellular cycle of vesicle formation and fusion with endosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.309

GLUT4 retention in adipocytes requires two intracellular insulin-regulated transport steps

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.309

GLUT4 distribution between the plasma membrane and the intracellular compartments is maintained by an insulin-modulated bipartite dynamic mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.309

Insulin increases cell surface GLUT4 levels by dose dependently discharging GLUT4 into a cell surface recycling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.309

Full intracellular retention of GLUT4 requires AS160 Rab GTPase activating protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.309

Microtubule network is required for insulin signaling through activation of Akt/protein kinase B: evidence that insulin stimulates vesicle docking/fusion but not intracellular mobility

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.309

Insulin-regulated release from the endosomal recycling compartment is regulated by budding of specialized vesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.309

The GLUT4 glucose transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.309

Critical nodes in signalling pathways: insights into insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.309

The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits cell proliferation and increases markers of adipocyte maturation in cultured mouse 3T3 F442A preadipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.309

The formation of an insulin-responsive vesicular cargo compartment is an early event in 3T3-L1 adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.309

Insulin signaling through Akt/protein kinase B analyzed by small interfering RNA-mediated gene silencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.309

Insulin signaling diverges into Akt-dependent and -independent signals to regulate the recruitment/docking and the fusion of GLUT4 vesicles to the plasma membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.309

Pharmacology of cannabinoid CB1 and CB2 receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.309

Endocannabinoids in adipocytes during differentiation and their role in glucose uptake.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.309

Lentiviral short hairpin ribonucleic acid-mediated knockdown of GLUT4 in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.309

Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.309

21 January 2018

Cannabinoid signalling

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.309

The endocannabinoid system: mechanisms behind metabolic homeostasis and imbalance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.309

Mechanism of extracellular signal-regulated kinase activation by the CB(1) cannabinoid receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.309

Activation of phosphoinositide 3-kinase/PKB pathway by CB(1) and CB(2) cannabinoid receptors expressed in prostate PC-3 cells. Involvement in Raf-1 stimulation and NGF induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.309

Regulation of PI3K/Akt/GSK-3 pathway by cannabinoids in the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.309

Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.309

Endogenous cannabinoids in the brain and peripheral tissues: regulation of their levels and control of food intake.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.309

The CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.309

Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.309

Development of insulin-responsive glucose uptake and GLUT4 expression in differentiating human adipocyte precursor cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.309

The endogenous cannabinoid system stimulates glucose uptake in human fat cells via phosphatidylinositol 3-kinase and calcium-dependent mechanisms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.309

The CB1 cannabinoid receptor is coupled to the activation of protein kinase B/Akt

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.309

Pharmacological actions of cannabinoids.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.309

Interleukin-2 suppression by 2-arachidonyl glycerol is mediated through peroxisome proliferator-activated receptor gamma independently of cannabinoid receptors 1 and 2.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.309

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/OBY.2008.309

1 reference

7 November 2017

1 reference